Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients

Next Previous
Search
Trial Profile

Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fimasartan (Primary)
  • Indications Diastolic heart failure
  • Focus Therapeutic Use
  • Acronyms FINE

Most Recent Events

  • 29 Dec 2015 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
  • 22 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Aug 2015 as per ClinicalTrials.gov record.
  • 22 Jun 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Aug 2015 as per ClinicalTrials.gov record..

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top